GlaxoSmithKline boosts its oncology product line as it swoops for American drug developer in US$1.9bn dealProactive Investors • 04/13/22
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bnBusiness Wire • 04/13/22
CureVac, GSK ink 'pandemic preparedness' agreement through 2029 with German governmentMarket Watch • 04/11/22
Coronvirus tally: FDA pulls Glaxo COVID treatment ahead of panel meeting on next steps for 2022Market Watch • 04/06/22
FDA Says Current Dose Of GSK-Vir's COVID-19 Therapy Unlikely To Work Against Omicron SubvariantBenzinga • 03/28/22
BiondVax Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Business UpdatePRNewsWire • 03/28/22